Pharmacokinetics and Pharmacodynamics of Darunavir and Etravirine in HIV-1-Infected, Treatment-Experienced Patients in the Gender, Race, and Clinical Experience (GRACE) Trial.
about
Insights on GRACE (Gender, Race, And Clinical Experience) from the patient's perspective: GRACE participant surveyNon-nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerabilityInteraction between Darunavir and Etravirine Is Partly Mediated by CYP3A5 PolymorphismPharmacokinetics of Once-Daily Darunavir/Ritonavir With and Without Etravirine in Human Immunodeficiency Virus-Infected Children, Adolescents, and Young Adults.Darunavir and ritonavir total and unbound plasmatic concentrations in HIV-HCV-coinfected patients with hepatic cirrhosis compared to those in HIV-monoinfected patientsClinical pharmacokinetics of antiretroviral drugs in older persons.Etravirine Pharmacokinetics in HIV-Infected Pregnant Women.Caring for women living with HIV: gaps in the evidence.Pharmacokinetic Evaluation of Darunavir Administered Once or Twice Daily in Combination with Ritonavir or the Three-Direct-Acting Antiviral Regimen of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults Coinfected with Hepatitis C and Human ImEtravirine combined with antiretrovirals other than darunavir/ritonavir for HIV-1-infected, treatment-experienced adults: Week 48 results of a phase IV trial.Darunavir: a review of its use in the management of HIV-1 infection.Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study.Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis.
P2860
Q24605774-F5BC47FB-49CD-4405-986C-AD1C27F5A749Q24628212-C4298244-7656-46BE-8D41-731649ED87EAQ28552997-54121847-B6A6-42EC-891F-5E409D2DEDFEQ33609231-A9A8CDFF-AE30-44B0-92F9-063E49B3BDD7Q36158135-2BA3FC51-7D95-463E-9E18-AC12189538B4Q36905884-BA1E2FC1-E404-44ED-AFCF-2D1CC350D26BQ37150339-C3098556-9490-413C-8BA2-16A5E0CE3BFFQ37212049-4C48690A-75DC-4D65-BF25-D0620471963DQ37612932-8FC148C8-E38C-40CF-B757-D8673C252445Q37722935-3FDB6BED-425E-4894-B346-4F7B3CEA8D6BQ38171346-E85E8626-2CA2-4009-BF36-B380252F8F8EQ39033125-52EDF513-0B77-4218-A2EC-8707CEBEA374Q42228170-7B124FE1-3A5B-4815-B281-E61C14C15B09
P2860
Pharmacokinetics and Pharmacodynamics of Darunavir and Etravirine in HIV-1-Infected, Treatment-Experienced Patients in the Gender, Race, and Clinical Experience (GRACE) Trial.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Pharmacokinetics and Pharmacod ...... ical Experience (GRACE) Trial.
@ast
Pharmacokinetics and Pharmacod ...... ical Experience (GRACE) Trial.
@en
type
label
Pharmacokinetics and Pharmacod ...... ical Experience (GRACE) Trial.
@ast
Pharmacokinetics and Pharmacod ...... ical Experience (GRACE) Trial.
@en
prefLabel
Pharmacokinetics and Pharmacod ...... ical Experience (GRACE) Trial.
@ast
Pharmacokinetics and Pharmacod ...... ical Experience (GRACE) Trial.
@en
P2093
P2860
P356
P1476
Pharmacokinetics and Pharmacod ...... ical Experience (GRACE) Trial.
@en
P2093
Bruce Coate
David Anderson
Guy De La Rosa
Joseph Mrus
Robert Ryan
Thomas Kakuda
Vanitha Sekar
P2860
P304
P356
10.1155/2012/186987
P577
2012-03-21T00:00:00Z